Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lyme disease.

A C Steere1

  • 1Division of Rheumatology/Immunology, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111.

The New England Journal of Medicine
|August 31, 1989
PubMed
Summary
This summary is machine-generated.

Lyme borreliosis, a worldwide tick-borne infection caused by Borrelia burgdorferi, presents with diverse symptoms and requires timely antibiotic treatment. Early diagnosis via serology and prompt treatment are key for managing this complex disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mimicry and Lyme arthritis.

Current directions in autoimmunity·2002
Same author

Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.

Infection and immunity·2001
Same author

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Optic neuropathy in children with Lyme disease.

Pediatrics·2001
Same author

Lyme disease.

The New England journal of medicine·2001
Same author

Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment.

The Journal of infectious diseases·2001
Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients. Reply.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Microbiology

Background:

  • Lyme borreliosis is an emerging global infectious disease caused by the spirochete Borrelia burgdorferi.
  • Transmission occurs via ticks from the Ixodes ricinus complex, with mice and deer playing critical roles in the pathogen's life cycle.
  • Regional variations exist in the spirochete, hosts, and clinical presentations of Lyme disease.

Purpose of the Study:

  • To provide a comprehensive overview of Lyme borreliosis.
  • To highlight the global distribution and etiological agent.
  • To describe the clinical manifestations, diagnosis, and treatment.

Main Methods:

  • Literature review of Lyme borreliosis.
  • Analysis of epidemiological data.

Related Experiment Videos

  • Summary of clinical findings and diagnostic approaches.

    • Main Results:

    • Lyme disease manifests with erythema migrans and flu-like symptoms, progressing to potential neurologic, cardiac, and musculoskeletal issues.
    • Serologic antibody response is a practical diagnostic aid.
    • Antibiotic treatment is generally curative, though prolonged courses may be necessary for later-stage illness.

    Conclusions:

    • Lyme borreliosis is a complex, globally distributed infection requiring careful management.
    • Early diagnosis and appropriate antibiotic therapy are crucial for effective treatment outcomes.
    • Ongoing research is needed to address treatment challenges and regional variations.